2WHO . Progress towards global poliomyelitis eradication: preparation for the oral poliovirus vaccine cessation era [J] . WER,2004,79 ( 39 ) : 349-355.
3Dowdle WR,De Gourville E,Kew OM,et al . Polio eradication: the OPV paradox[J] . Rev Med Virol,2003,13L277-291.
4Kew OM,Wright PF,Agol VI,et al . Circulation vaccine-derived polioviruses: current state of knowledge [J] . Bull World Health Organ, 2004,82:31-39.
5Kew OM,Sutter RW,De Gourville EM,et al . Vaccine-Derived Polioviruses and the Endgame Strategy for Global Polio Eradication [J] . Armu Rev Microbiol,2005,59:587-635.
6CDC . Poliovirus infections in four unvaccinated children Minnesota, August-October 2005[J] . MMWR,2005,54(41 ) : 1053-I055.
7Sutter RW,Caceres VM,Mas L,et al . The role of routine polio immunization in the post-certification era [J] . Bull World Health Organ, 2004,82:31-39.
8Aylward RB, Sutter RW,Heymarm DL . Policy: OPV cessation the final step to a "polio-free" world [J] . Science,2005,310(5748): 625 -626.
9Yang CF,Naguib T,Yang SJ,et al . Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993 [J] . J Viral, 2003,77:8366-8377.
10CDC . Outbreak of poliomyelitis-Dominican Republic and Haiti, 2000-2001[J]. MMWR,2001,50(40):855-856.
3[1]Horaud F,Albert B.Sabin and the development of oral polio vaccine[J].Biological,1993,21:311-316.
4[2]Kew O M,Nottay B K,Hatch M H,et al.Multiple genetic changes can occur in the oral polio vaccines upon replication in humans[J].J Gen Virol,1998,156:337-347.
5[3]Balanat J,Guillot S,Candrea A,et al.The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay[J].Virology,1991,184:645-654.
6[4]Bouchard M J,Lam D H,Racaniello V R,et al.Determinants of Attenuation and Temperature Sensitivity in the Type Ⅰ Poliovirus Sabin Vaccine[J].J Virology,1995,69(8):4972-4978.
7[5]Ren R B,Moss E G,Racaniello V R,et al.Identification of Two Determinants that Attenuate Vaccine-Related Type Ⅱ Poliovirus[J].J Virology,1991,65(3):1377-1382.
8[6]Almond J W,Westrop G D,Evans D M A,et al.Studies on the Attenuation of the Sabin Type Ⅲ Oral Polio Vaccine[J].J Virol Meth,1987,17:183-189.
9[7]Joce R,Wood D,Brown D,et al.Paralytic Poliomyelitis in England and Wales,1985-91[J].Br Med J,1992,305:79-82.
10[8]Almond J W.The Attenuation of Poliovirus Neurovirulence[J].Microbiol,1987,41:153-180.
3Shohreh Shahmahmoodi,Nina Parvaneh,Cara Bums . Isolation of a type 3 vaccine-derived poliovirus ;(VDPV)from an Iranian child with X-linked agammaglobulinemia [J] . Virus Research, 2008,137( 1 ) : 168-172.
4Pooneh Rahini, H. Tabatabaie, Mohammad M et al . Characterization of mutations in the VP1 region of Sabin strain type 1 polioviruses isolated from vaccine-assosiated paralytic poliomyelitis cases in Iran Pooneh Rahini[ J ] . Journal of Clinical Virology, 2007,39(4) : 304-307.
